Search alternatives:
differences areas » differences across (Expand Search), different areas (Expand Search), differences remains (Expand Search)
sizes decrease » size increase (Expand Search), scores decreased (Expand Search)
mean decrease » a decrease (Expand Search)
differences areas » differences across (Expand Search), different areas (Expand Search), differences remains (Expand Search)
sizes decrease » size increase (Expand Search), scores decreased (Expand Search)
mean decrease » a decrease (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.
Published 2025“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”
-
7
-
8
-
9
-
10
Spatial information is significantly decreased in dCA1 and vCA1 in APP/PS1 mice.
Published 2024“…(B) In dCA1, spatial information was decreased in APP/PS1 mice relative to C57BL/6 controls (mean ± std: C57BL/6 = 0.132 ± 0.048, APP/PS1 = 0.128 ± 0.051, p < 0.005, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 305 units from 5 recording sessions, n<sub>APP/PS1</sub> = 180 units from 4 recording sessions). …”
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Graph of wear volume variation for test groups with different particle sizes at two concentrations.
Published 2025Subjects: -
19
-
20